Drug design, development and therapy - JoVE Visualize

Showing results (1261-1270 of 5,679) with videos related to

Pageof 568

Sort By:

Drug Design, Development and Therapy|March 23, 2026

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)Laurens A Van Kleef, Maurice Michel, Naim Alkhouri, et al.

Drug Design, Development and Therapy|March 23, 2026

The Effect of AZD5153 on Radiosensitivity in Pancreatic Cancer Cells Through ATM-chk1 PathwayLulin Zhu, Rong Dong, Gezi Yan, et al.

Drug Design, Development and Therapy|March 23, 2026

Prophylactic Efficacy of Cipepofol Against Postoperative Nausea and Vomiting in Moderate to High-Risk Patients of Apfel Score: A Multicenter, Randomized, and Parallel-Group Comparative TrialJia Deng, Jing He, Peiyu Li, et al.

Drug Design, Development and Therapy|March 23, 2026

Determination of ED50 and ED95 for Ciprofol in Morbidly Obese Patients During Induction of General Anesthesia: A Single-Center, Up-and-Down Study Based on Lean Body WeightChao-Min Wu, Ji-Min Wu, Jian-Xin Jiang, et al.

Drug Design, Development and Therapy|May 1, 2026

Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC TransportersKexin Lin, Tingyu Li, Xiaorui Kong, et al.

Drug Design, Development and Therapy|May 27, 2026

Determination of the ED90 and ED99 of Liposomal versus Conventional Bupivacaine for Ultrasound-Guided Stellate Ganglion Block: A Biased-Coin Design StudyLitong Yang, Junxiang Liu, Yutong Yang, et al.

Drug Design, Development and Therapy|May 27, 2026

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 TrialJong-Chan Youn, Eui-Soon Kim, Tae Ho Park, et al.

Drug Design, Development and Therapy|May 27, 2026

Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality ControlJing Liu, Fuxing Li, Qianru Zeng, et al.

Drug Design, Development and Therapy|May 27, 2026

An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in RatHuanchen Li, Hongkun Wu, Shouhong Gao, et al.

Drug Design, Development and Therapy|May 27, 2026

Tegileridine, a Biased μ-Opioid Receptor Agonist, versus Oxycodone for Postoperative Analgesia and Postoperative Nausea and Vomiting After Total Laparoscopic Hysterectomy: A Randomized, Double-Blind, Single-Center, Controlled TrialYu Fu, Xin Chen, Fang-Peng Gao, et al.

Pageof 568

Showing results (1261-1270 of 5,679) with videos related to

Sort By:

Pageof 568

Drug Design, Development and Therapy|March 23, 2026

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)Laurens A Van Kleef, Maurice Michel, Naim Alkhouri, et al.

Drug Design, Development and Therapy|March 23, 2026

The Effect of AZD5153 on Radiosensitivity in Pancreatic Cancer Cells Through ATM-chk1 PathwayLulin Zhu, Rong Dong, Gezi Yan, et al.

Drug Design, Development and Therapy|March 23, 2026

Prophylactic Efficacy of Cipepofol Against Postoperative Nausea and Vomiting in Moderate to High-Risk Patients of Apfel Score: A Multicenter, Randomized, and Parallel-Group Comparative TrialJia Deng, Jing He, Peiyu Li, et al.

Drug Design, Development and Therapy|March 23, 2026

Determination of ED50 and ED95 for Ciprofol in Morbidly Obese Patients During Induction of General Anesthesia: A Single-Center, Up-and-Down Study Based on Lean Body WeightChao-Min Wu, Ji-Min Wu, Jian-Xin Jiang, et al.

Drug Design, Development and Therapy|May 1, 2026

Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC TransportersKexin Lin, Tingyu Li, Xiaorui Kong, et al.

Drug Design, Development and Therapy|May 27, 2026

Determination of the ED90 and ED99 of Liposomal versus Conventional Bupivacaine for Ultrasound-Guided Stellate Ganglion Block: A Biased-Coin Design StudyLitong Yang, Junxiang Liu, Yutong Yang, et al.

Drug Design, Development and Therapy|May 27, 2026

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 TrialJong-Chan Youn, Eui-Soon Kim, Tae Ho Park, et al.

Drug Design, Development and Therapy|May 27, 2026

Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality ControlJing Liu, Fuxing Li, Qianru Zeng, et al.

Drug Design, Development and Therapy|May 27, 2026

An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in RatHuanchen Li, Hongkun Wu, Shouhong Gao, et al.

Drug Design, Development and Therapy|May 27, 2026

Tegileridine, a Biased μ-Opioid Receptor Agonist, versus Oxycodone for Postoperative Analgesia and Postoperative Nausea and Vomiting After Total Laparoscopic Hysterectomy: A Randomized, Double-Blind, Single-Center, Controlled TrialYu Fu, Xin Chen, Fang-Peng Gao, et al.

Pageof 568